AK-01

Investigational

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C24H26ClF2N5O2
Molecular Weight	489.945
Optical Activity	UNSPECIFIED
Defined Stereocenters	2 / 2
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

C[C@@H]1C[C@@](CC2=NC(NC3=NNC(C)=C3)=CC=C2F)(CCN1CC4=CC=CC(Cl)=C4F)C(O)=O

InChI

InChIKey=YQQZZYYQTCPEAS-OYLFLEFRSA-N

InChI=1S/C24H26ClF2N5O2/c1-14-10-21(31-30-14)29-20-7-6-18(26)19(28-20)12-24(23(33)34)8-9-32(15(2)11-24)13-16-4-3-5-17(25)22(16)27/h3-7,10,15H,8-9,11-13H2,1-2H3,(H,33,34)(H2,28,29,30,31)/t15-,24-/m1/s1

HIDE SMILES / InChI

Molecular Formula	C24H26ClF2N5O2
Molecular Weight	489.945
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	2 / 2
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

C_max

Value	Dose	Analyte	Population
17900 μg/L REVIEW https://link.springer.com/article/10.1007/s10637-020-01049-3	50 mg 2 times / day multiple, oral dose: 50 mg route of administration: Oral experiment type: MULTIPLE co-administered:	LY3295668 plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN
17900 μg/L EXPERIMENT https://aacrjournals.org/cancerres/article/79/13_Supplement/CT019/637613	25 mg 2 times / day multiple, oral dose: 25 mg route of administration: Oral experiment type: MULTIPLE co-administered:	LY3295668 plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN
3350 μg/L REVIEW https://link.springer.com/article/10.1007/s10637-020-01049-3	25 mg single, oral dose: 25 mg route of administration: Oral experiment type: SINGLE co-administered:	LY3295668 plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN

AUC

Value	Dose	Analyte	Population
128000 μg × h/L REVIEW https://link.springer.com/article/10.1007/s10637-020-01049-3	50 mg 2 times / day multiple, oral dose: 50 mg route of administration: Oral experiment type: MULTIPLE co-administered:	LY3295668 plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN
128000 μg × h/L EXPERIMENT https://aacrjournals.org/cancerres/article/79/13_Supplement/CT019/637613	25 mg 2 times / day multiple, oral dose: 25 mg route of administration: Oral experiment type: MULTIPLE co-administered:	LY3295668 plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN
20800 μg × h/L REVIEW https://link.springer.com/article/10.1007/s10637-020-01049-3	25 mg single, oral dose: 25 mg route of administration: Oral experiment type: SINGLE co-administered:	LY3295668 plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN

T_1/2

Value	Dose	Co-administered	Analyte	Population
21 h EXPERIMENT https://aacrjournals.org/cancerres/article/79/13_Supplement/CT019/637613	25 mg 2 times / day multiple, oral dose: 25 mg route of administration: Oral experiment type: MULTIPLE co-administered:		LY3295668 plasma	Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN

Substance Class	Chemical Created by `admin` on `Wed Apr 02 00:41:24 GMT 2025` Edited by `admin` on `Wed Apr 02 00:41:24 GMT 2025`
Record UNII	1WX8O5XV4R
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

AK-01

Code

English

LY-3295668

Preferred Name

English

1-((3-CHLORO-2-FLUOROPHENYL)METHYL)-4-((3-FLUORO-6-((5-METHYL-1H-PYRAZOL-3-YL)AMINO)-2-PYRIDINYL)METHYL)-2-METHYL-, (2R,4R)-,4-PIPERIDINECARBOXYLIC ACID

Systematic Name

English

LY3295668

Code

English

AURORA A KINASE INHIBITOR LY3295668

Common Name

English

4-PIPERIDINECARBOXYLIC ACID, 1-((3-CHLORO-2-FLUOROPHENYL)METHYL)-4-((3-FLUORO-6-((5-METHYL-1H-PYRAZOL-3-YL)AMINO)-2-PYRIDINYL)METHYL)-2-METHYL-, (2R,4R)-

Systematic Name

English

Classification Tree Code System Code

FDA ORPHAN DRUG

724119